U.S. Food and Drug Administration
(https://www.fda.gov) 📸 Data Snapshot: May 19, 2026Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
The site exhibits zero heading fluff, with H1 and H4 tags utilizing high-specificity nouns and technical terms like ‘Post-Market Assessment Program,’ ‘BHT, ADA,’ and ‘National Priority Voucher Pilot Program.’ Body text maintains a high substance ratio, citing ‘chemical contaminants in infant formula’ and specific gene therapy treatments for ‘genetic hearing loss.’ There is no evidence of concept repetition; every press announcement and featured topic introduces distinct, measurable regulatory actions. Specificity is maximized through the use of exact dates (May 12, 2026) and specific legal/technical frameworks (483s, EUAs, 510Ks).
Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.
📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE (https://www.fda.gov) U.S. Food and Drug Administration
Topic Paragraphs [IMG: Woman looking at cans of infant formula in a store] [H1] FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S. The FDA announced results from the largest and most rigorous examination ever conducted focused on chemical contaminants in infant formula available on the U.S. market. While breast milk is widely considered the gold standard and optimal source of nutrition for infants whenever possible, millions of parents depend on formula. [H3] Featured Topics Recalls Report a Problem Warning Letters Consumer Updates 483s EUAs 510Ks Guidance Documents Drug Databases Import Program [H3] FDA in Action FDA Voices: How FDA is Implementing Landmark Cosmetics Legislation to Positively Impact Public Health FDA Achieves Year 1 Goals in Reducing Animal Testing in Drug Development FDA Takes Action to Advance Gene Therapy Development FDA PreCheck Pilot Program Strengthens Domestic Pharmaceutical Manufacturing Agency Unveils Real-Time Trial Proofs-of-Concept and Upcoming Pilot Program FDA Finalizes Food Chemical Safety Post-Market Assessment Program, Launches Reassessment of BHT, ADA FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss [H3] Press Announcements May 12, 2026 [H4] FDA Finalizes Food Chemical Safety Post-Market Assessment Program, Launches Reassessment of BHT, ADA May 11, 2026 [H4] FDA Advances Drug Repurposing to Address Unmet Medical Needs May 08, 2026 [H4] FDA Grants Seventh Approval under the National Priority Voucher Pilot Program Newsroom [H3] Products We Regulate Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood, and Biologics Animal and Veterinary Cosmetics Tobacco Products
SUB-PAGE · THIN (https://fda.gov/about-fda/about-website/language-assistance-services/)
Not found
SUB-PAGE · THIN (https://fda.gov/about-fda/contact-fda/)
Not found
SUB-PAGE · THIN (https://fda.gov/about-fda/)
Not found
SUB-PAGE · THIN (https://fda.gov/regulatory-information/search-fda-guidance-documents/)
Not found
SUB-PAGE · THIN (https://fda.gov/safety/recalls-market-withdrawals-safety-alerts/)
Not found
🧭 Industry Context — common generic-claim patterns in Government, Municipal & Public Sector to weigh the text against
This page presents a snapshot of public data from U.S. Food and Drug Administration, captured on May 19, 2026, to show how machine logic reads Information Density signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to U.S. Food and Drug Administration: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://www.fda.gov to view the most current version of its content and see directly what this company is about and what it offers.